Factors associated with emergency department (ED) attendance during last month of life
the ONA take:
According to a new study published in the Journal of Clinical Oncology, researchers from King's College London Cicely Saunders Institute in London, United Kingdom, have identified demographic and environmental factors associated with an increased risk of emergency department visits by patients with cancer during the final month of life.
For the study, researchers sought to investigate factors associated with emergency department attendance by patients with cancer during the last month of their lives. They analyzed data from five electronic databases and identified 30 studies that investigated emergency department attendance at the end of the lives of patients with cancer.
The studies included nearly 1.2 million patients from five countries and reported 13 environmental, five clinical, and three demographic factors in total.
Results showed an increased risk of emergency department attendance was associated with black race (OR = 1.45; 95% CI: 1.40 - 1.50), male gender (OR = 1.24; 95% CI: 1.19 - 1.29), having lung cancer (OR = 1.17; 95% CI: 1.10 - 1.23), and those of low socioeconomic status (OR = 1.15; 95% CI: 1.10 - 1.19).
Patients receiving palliative care were less likely to have an emergency department visit during the last month of life (OR = 0.43; 95% CI: 0.36 - 0.51).
Demographic and environmental factors associated with an increased risk of emergency department visits by patients with cancer.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|